missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ VAV1/2/3 Recombinant Rabbit Monoclonal Antibody (24GB2645)
Rabbit Recombinant Monoclonal Antibody
€ 146.00 - € 500.00
Specifications
| Antigen | VAV1/2/3 |
|---|---|
| Clone | 24GB2645 |
| Content And Storage | -20°C |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Recombinant Monoclonal |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
30276460
|
Invitrogen™
MA557313 |
100 μL |
€ 500.00
100µL |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
30275034
|
Invitrogen™
MA557314 |
20 μL |
€ 146.00
20µL |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
VAV1/2/3 Recombinant Monoclonal Antibody for Western Blot, ICC/IF
The VAV gene family consists of three members: VAV1, VAV2, and VAV3, which are guanine nucleotide exchange factors (GEFs) primarily involved in signal transduction. VAV1, located on chromosome 19p13.2, is predominant in hematopoietic cells and plays a crucial role in T and B lymphocyte signaling, impacting immune responses and cell cycle control. This gene has been implicated in autoimmune diseases as well as several cancers. VAV2, found on chromosome 9q34.1, is ubiquitously expressed and is involved in various cellular processes, such as DNA repair mechanisms and vascular smooth muscle function, with significant implications in cancer where overexpression correlates with tumor progression. VAV3, located on chromosome 1p13.3, shares similar GEF roles and is actively involved in oncogenic processes by mediating Rho GTPase signaling, affecting cell proliferation, migration, and invasion, and is considered a target for cancer therapy. The structural conservation and functional diversity of these proteins underscore their importance in both normal cellular function and disease.Specifications
| VAV1/2/3 | |
| -20°C | |
| Recombinant Monoclonal | |
| Liquid | |
| IgG | |
| Human | |
| VAV1 | |
| 10451, 7409, 7410 | |
| A synthesized peptide derived from human Vav1/2/3 (aa 750-800). | |
| Antibody |
| 24GB2645 | |
| Western Blot, Immunocytochemistry | |
| Unconjugated | |
| Rabbit | |
| RUO | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| P15498, P52735, Q9UKW4 | |
| VAV1, VAV2, VAV3 | |
| Primary | |
| Affinity chromatography |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title